Apyx Medical Corporation Announces Subject Enrollment Initiated in New Study Evaluating the Use of Renuvion Technology in Dermal Resurfacing Procedures

Apyx Medical Corporation announces it has initiated subject enrollment in a US Investigational Device Exemption clinical study evaluating the use of its Renuvion technology in dermal resurfacing procedures.